Get the Stockscreener App
14.66
0.41%
-0.0471
Cvrx Inc stock is traded at $14.66, with a volume of 75,753.
It is down -0.41% in the last 24 hours and up +3.24% over the past month.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$14.71
Open:
$14.64
24h Volume:
75,753
Relative Volume:
0.31
Market Cap:
$372.53M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-5.4209
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
-8.32%
1M Performance:
+3.24%
6M Performance:
+72.35%
1Y Performance:
-40.35%
1-Day Range:
$14.37
$14.88
1-Week Range:
$13.84
$16.59
52-Week Range:
$6.40
$24.75
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx Inc
Sector
Industry
Phone
(763) 416-2850
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
14.66 | 372.53M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
129.11 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.54 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.73 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.00 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.22 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Sep-10-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-24 | Reiterated | Lake Street | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| May-01-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-31-23 | Initiated | Lake Street | Buy |
| Jul-18-22 | Initiated | Craig Hallum | Buy |
| Jul-26-21 | Initiated | Canaccord Genuity | Buy |
| Jul-26-21 | Initiated | Piper Sandler | Overweight |
| Jul-26-21 | Initiated | William Blair | Outperform |
View All
Cvrx Inc Stock (CVRX) Latest News
Wall Street Analysts Predict a 25.76% Upside in CVRx (CVRX): Here's What You Should Know - Yahoo Finance
Skechers Posts Downbeat Results, Joins e.l.f. Beauty, LiveRamp And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
FY2025 EPS Estimates for CVRx Decreased by Cantor Fitzgerald - Armenian Reporter
Calamos Advisors LLC Makes New Investment in CVRx, Inc. (NASDAQ:CVRX) - ETF Daily News
Canaccord Genuity Group Boosts CVRx (NASDAQ:CVRX) Price Target to $23.00 - Defense World
CVRx targets $63M-$65M revenue in 2025 with strengthened sales strategy - MSN
Piper Sandler Raises CVRx (NASDAQ:CVRX) Price Target to $20.00 - Defense World
CVRx Inc [CVRX] Shares Fall -7.20 % on Wednesday - Knox Daily
Should You Invest in CVRx Inc (CVRX) Now? - The News Heater
CVRx’s Earnings Call: Growth Amid Challenges - TipRanks
What 4 Analyst Ratings Have To Say About CVRx - Benzinga
CVRx stock dips on Q4 EPS miss - Mass Device
Objective long/short (CVRX) Report - Stock Traders Daily
CVRx Announces Strong Revenue Growth in 2024 - TipRanks
CVRx, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Earnings call transcript: CVRx Q4 2024 shows revenue growth, stock dips - MSN
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
CVRx: Q4 Earnings Snapshot -February 04, 2025 at 04:50 pm EST - Marketscreener.com
CVRx: Q4 Earnings Snapshot - Leader-Telegram
Earnings Flash (CVRX) CVRX INC. Reports Q4 Revenue $15.3M, vs. FactSet Est of $15.1M - Marketscreener.com
CVRx Earnings Showcase: Heart Failure Treatment Propels 41% Revenue Explosion in Core Market - StockTitan
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
CVRx Inc (CVRX) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
(CVRX) Technical Data - Stock Traders Daily
William Blair upgrades CVRx on stabilization of business - MSN
CVRx Inc (CVRX) Shares Down 4.32% on Jan 24 - GuruFocus.com
Analysts Issue Forecasts for CVRx FY2025 Earnings - Defense World
CVRx, Inc. (NASDAQ:CVRX) Stock Holdings Increased by Barclays PLC - Defense World
Analysts Set Expectations for CVRx FY2025 Earnings - MarketBeat
CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025 - The Manila Times
CVRx to Report Q4 2024 Financial Results for Barostim Device on February 4 - StockTitan
CVRx stock price target increased, buy rating on growth acceleration - MSN
CVRx (NASDAQ:CVRX) Reports Strong Financial Results for Q4 and Fiscal Year 2024; Issues 2025 Guidance - Defense World
Craig Hallum Forecasts Strong Price Appreciation for CVRx (NASDAQ:CVRX) Stock - Defense World
Craig Hallum Issues Positive Forecast for CVRx (NASDAQ:CVRX) Stock Price - MarketBeat
Where CVRx Stands With Analysts - Benzinga
CVRx stock price target increased, buy rating on growth acceleration By Investing.com - Investing.com Australia
CVRx (NASDAQ:CVRX) Upgraded at William Blair - Defense World
William Blair Has Bullish Estimate for CVRx FY2024 Earnings - Defense World
CVRx says total Q4 revenue is expected to be between $15.2M and $15.3M - MSN
CVRx (CVRX) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Equities Analysts Set Expectations for CVRx FY2024 Earnings - MarketBeat
CVRx (CVRX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 27% - Simply Wall St
Cvrx Inc Stock (CVRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvrx Inc Stock (CVRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER |
Nov 19 '24 |
Option Exercise |
5.14 |
2,500 |
12,852 |
3,305 |
| VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER |
Nov 19 '24 |
Sale |
13.58 |
1,430 |
19,417 |
1,875 |
0.93%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):